<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2009 (6) TMI 685 - ITAT MUMBAI</title>
    <link>https://www.taxtmi.com/caselaws?id=121366</link>
    <description>The court ruled in favor of the assessee in part, dismissing the revenue&#039;s appeal. The sale of Howmedica business was treated as an itemized sale rather than a slump sale. The reimbursement from Pfizer Inc. was deemed a short-term capital gain, with deductions allowed. The write-off in closing stock was accepted as a legitimate business expense. The case was remanded to determine the net worth for computing capital gains from the slump sale.</description>
    <language>en-us</language>
    <pubDate>Fri, 12 Jun 2009 00:00:00 +0530</pubDate>
    <lastBuildDate>Mon, 30 Jul 2012 12:06:13 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=158360" rel="self" type="application/rss+xml"/>
    <item>
      <title>2009 (6) TMI 685 - ITAT MUMBAI</title>
      <link>https://www.taxtmi.com/caselaws?id=121366</link>
      <description>The court ruled in favor of the assessee in part, dismissing the revenue&#039;s appeal. The sale of Howmedica business was treated as an itemized sale rather than a slump sale. The reimbursement from Pfizer Inc. was deemed a short-term capital gain, with deductions allowed. The write-off in closing stock was accepted as a legitimate business expense. The case was remanded to determine the net worth for computing capital gains from the slump sale.</description>
      <category>Case-Laws</category>
      <law>Income Tax</law>
      <pubDate>Fri, 12 Jun 2009 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=121366</guid>
    </item>
  </channel>
</rss>